NEW YORK (GenomeWeb News) – Luminex today announced that its public offering of 3.5 million shares of common stock, which is expected to close on June 30, will price at $19.91 per share.
 
The Austin, Texas-based firm expects to realize net proceeds of $64.5 million from the offering. It also has granted underwriters a 30-day option to acquire an additional 525,000 shares of common stock to cover any over-allotments.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.